Filters

20232
Reset filters

Settings

Author: Ramalingam, MuruganSubject: Nanomaterials

Search Results

Now showing 1 - 2 of 2
  • Thumbnail Image
    Review
    Citation - WoS: 27
    Citation - Scopus: 45
    Impact of Nanotechnology on Conventional and Artificial Intelligence-Based Biosensing Strategies for the Detection of Viruses
    (Springer, 2023) Ramalingam, Murugan; Jaisankar, Abinaya; Cheng, Lijia; Krishnan, Sasirekha; Lan, Liang; Hassan, Anwarul; Marrazza, Giovanna
    Recent years have witnessed the emergence of several viruses and other pathogens. Some of these infectious diseases have spread globally, resulting in pandemics. Although biosensors of various types have been utilized for virus detection, their limited sensitivity remains an issue. Therefore, the development of better diagnostic tools that facilitate the more efficient detection of viruses and other pathogens has become important. Nanotechnology has been recognized as a powerful tool for the detection of viruses, and it is expected to change the landscape of virus detection and analysis. Recently, nanomaterials have gained enormous attention for their value in improving biosensor performance owing to their high surface-to-volume ratio and quantum size effects. This article reviews the impact of nanotechnology on the design, development, and performance of sensors for the detection of viruses. Special attention has been paid to nanoscale materials, various types of nanobiosensors, the internet of medical things, and artificial intelligence-based viral diagnostic techniques.
  • Thumbnail Image
    Review
    Citation - WoS: 7
    Citation - Scopus: 7
    Recent Advances in Nanomedicine Development for Traumatic Brain Injury
    (Churchill Livingstone, 2023) Ling, Yating; Ramalingam, Murugan; Lv, Xiaorui; Zeng, Yu; Qiu, Yun; Si, Yu; Hu, Jiabo
    Traumatic brain injury (TBI) is one of the major causes of morbidity and mortality worldwide, and it is also a risk factor for neurodegeneration. However, there has not been perceptible progress in treating acute TBI over the last few years, mainly due to the inability of therapeutic drugs to cross the blood-brain barrier (BBB), failing to exert significant pharmacological effects on the brain parenchyma. Recently, nanomedicines are emerging as a powerful tool for the treatment of TBI where nanoscale materials (also called nanomaterials) are employed to deliver therapeutic agents. The advantages of using nanomaterials as a drug carrier include their high solubility and stability, high carrier capacity, site-specific, improved pharmacokinetics, and biodistribution. Keeping these points in consideration, this article reviews the pathophysiology, current treatment options, and emerging nanomedicine strategies for the treatment of TBI. The review will help readers to gain insight into the state-of-the-art of nanomedicine as a new tool for the treatment of TBI.